Last updated on March 2019

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies


Brief description of study

A Phase 1/2, Open-Label, Dose-Escalation, Safety and Tolerability Study of INCB054828 in Subjects With Advanced Malignancies

Detailed Study Description

The purpose of this study will be to evaluate the safety, tolerability, and pharmacological activity of INCB054828 in subjects with advanced malignancies. This study will have three parts, dose escalation (Part 1), dose expansion (Part 2) and combination therapy (Part 3).

Clinical Study Identifier: TX145636

Find a site near you

Start Over

Research Center

Located in: Ann Arbor, MI USA
  Connect »

Research Center

Located in: Birmingham, AL USA
  Connect »

Research Center

Located in: New Haven, CT USA
  Connect »

Research Center

Located in: Middletown, OH USA
  Connect »

Research Center

Located in: Hackensack, NJ USA
  Connect »

Research Center

Located in: Durham, NC USA
  Connect »

Research Center

Located in: Houston, TX USA
  Connect »

Research Center

Located in: Port St. Lucie, FL USA
  Connect »

Research Center

Located in: Cleveland, OH USA
  Connect »

Research Center

Located in: St. Louis, MO USA
  Connect »

Research Center

Located in: Greenville, SC USA
  Connect »

Research Center

Located in: Dallas, TX USA
  Connect »

Research Center

Located in: Los Angeles, CA USA
  Connect »

Research Center

Located in: San Antonio, TX USA
  Connect »

Research Center

Located in: Washington, DC USA
  Connect »

Research Center

Located in: Tuscaloosa, Alabama USA
  Connect »

Research Center

Located in: Columbus, Ohio United States
  Connect »

Research Center

Located in: Copenhagen, Denmark
  Connect »